GlassScriptPhysician profile
Amrit Kanwar
NPI 1457915829
$3,868.10
in general payments reported to CMS, 2019-2025
23 companies · $737 in 2025
The $737 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $917 · 2023: $1,039 · 2024: $1,175 · 2025: $737.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,714 · Education: $237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,714.26 |
| Education | $237.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $585.47 | 2022-2025 | Cobalt Dr Mri Surescan, Linq II, Micra |
| Inari Medical, INC. | $574.62 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novo Nordisk INC | $468.62 | 2022-2025 | Wegovy |
| Boston Scientific Corporation | $427.28 | 2024-2025 | Watchman Flx, Emblem Mri S-Icd, Lux-Dx Insertable Cardiac Monitor |
| Abbott Laboratories | $261.28 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit, Jot Dx |
| Biotronik INC. | $222.38 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $176.53 | 2022-2023 | Farxiga |
| Sanofi-Aventis U.S. LLC | $174.00 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $127.84 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $114.74 | 2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $110.48 | 2025 | Assure Wcd |
| Lantheus Medical Imaging, INC. | $105.89 | 2022-2025 | Definity |
| Terumo Medical Corporation | $103.00 | 2024 | Azur Cx Detachable |
| Pfizer INC. | $90.70 | 2022-2025 | |
| Amgen INC. | $69.84 | 2022-2024 | Repatha |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $61.80 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiva Medical, INC. | $50.00 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Edwards Lifesciences Corporation | $35.59 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abiomed | $31.12 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $26.39 | 2023 | |
| Lexicon Pharmaceuticals, INC. | $23.32 | 2024 | Inpefa |
| Merck Sharp & Dohme LLC | $13.97 | 2025 | Verquvo |
| Philips North America LLC | $13.24 | 2024 | (Ck4) Mcot |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amrit Kanwar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.